Type
. Activity of repository sulfones against Mycobacterium leprae in mice. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 1967;124(2):430-3.
Type
. The effect of procarbazine on leprosy. Leprosy review [Internet]. 1967;38(1):11-4. Available from: http://leprev.ilsl.br/pdfs/1967/v38n1/pdf/v38n1a03.pdf
Type
. Lepromin and Kveim antigen reactivity in man, and their relation to tuberculin reactivity. British medical bulletin. 1967;23(1):80-5.
Type
. Histochemical changes in the tissues of different types of leprous lesions. Indian journal of dermatology. 1967;12(2):76-83.
Type
. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1967;35(1):25-33.
Type
. Histochemical changes in the tissues of different types of leprous lesions. Indian journal of dermatology. 1966;12(1):20-32 contd.
Type
. Demodicidiasis and leprosy. Leprosy review [Internet]. 1966;37(4):209-16. Available from: http://leprev.ilsl.br/pdfs/1966/v37n4/pdf/v37n4a03.pdf
Type
. A clinical trial of sulforthomidine ('Fanasil' Roche) in lepromatous leprosy. Leprosy review [Internet]. 1966;37(4):205-8. Available from: http://leprev.ilsl.br/pdfs/1966/v37n4/pdf/v37n4a02.pdf
Type
. Leprosy. Tropical diseases bulletin. 1966;63(9):921-39.
Type
. Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature. 1966;211(5049):657-8.